Terconazole

• Description:

  Terconazole is a broad-spectrum antifungal medication for the treatment of vaginal yeast infection.

• Product Name Alternative:

  R42470

• UNSPSC:

  12352005

• Hazard Statement:

  H315, H319, H335, H413

• Target:

  Fungal

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/Terconazole.html

• Purity:

  99.93

• Solubility:

  DMSO : ≥ 30 mg/mL

• Smiles:

  CC(N1CCN(C2=CC=C(OC[C@@H]3O[C@@](CN4N=CN=C4)(C5=CC=C(Cl)C=C5Cl)OC3)C=C2)CC1)C

• Molecular Formula:

  C26H31Cl2N5O3

• Molecular Weight:

  532.46

• Precautions:

  H315, H319, H335, H413

• References & Citations:

  [1]Tolman EL, et al. Anticandidal activities of terconazole, a broad-spectrum antimycotic. Antimicrob Agents Chemother. 1986 Jun;29 (6) :986-91.|[2]Van Cutsem J, et al. The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats. Am J Obstet Gynecol. 1991 Oct;165 (4 Pt 2) :1200-6.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  Launched

• CAS Number:

  67915-31-5